TYSON 2.0 and Carma HoldCo Inc have teamed up with PHCANN International (PHCANN), a multinational pharmaceutical company, to exclusively cultivate, manufacture and distribute THC products such as flower, concentrates and consumables across Germany and the United Kingdom.

"Collaborating with PHCANN to bring my premium TYSON 2.0 cannabis products to Germany and the UK is a natural move as industry heavyweights," said Mike Tyson, TYSON 2.0 co-founder and chief brand officer. "I'm excited to make our world-class products available to medical cannabis patients in the region. Together, we're setting new standards and delivering something that no one else is bringing to the table."

PHCANN International aims to provide high-quality cannabinoid-based products to patients and consumers worldwide. Operating from one of the largest European facilities in strict adherence to EU GMP standards, the company is headquartered in Amsterdam, Netherlands, with subsidiaries in North Macedonia, Poland and Germany.

"This is a pivotal moment in the progress of the industry in Europe,” said PHCANN International CEO Sasho Stefanoski. “We embrace this opportunity as many countries look toward regulatory changes. To partner with the TYSON 2.0 brand and join forces as well-respected industry leaders puts us in a position where we can lead the charge in pushing industry boundaries."

This partnership follows TYSON 2.0’s establishment of a branded coffee shop in Amsterdam and its expansion to Thailand through collaboration with Medican dba Frost.

"This venture marks a significant milestone in our mission to expand our global presence and provide quality products to consumers worldwide,” said Carma HoldCo CEO Adam Wilks. “With the TYSON 2.0 brand, we are excited to partner with PHCANN because of its track record of pushing the boundaries in European and other international markets and operating at a level above the current standard. By joining forces, we can deliver transformative experiences to medical cannabis consumers in Germany and the UK while leveraging our cultural influence to make a meaningful impact on the market."